Allotment of scrip shares to Directors

RNS Number : 6912W

The MedicX Fund Limited

02 January 2014

 



Press Release

For immediate release                                                                                    

2 January 2014

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Allotment of scrip shares to Directors of the Company

Members of the Company's Board of Directors elected to participate in the Company's scrip dividend scheme in respect of the December 2013 interim dividend for the quarter ended 30 September 2013, and accordingly acquired ordinary shares of no par value in the Company (the "Shares") as disclosed in the table below.  The Shares were sold out of treasury by the Company at the previously advised scrip calculation price of 80.55 pence per Share.

	Shares Acquired	Total Shares held	Percentage Holding
David Staples (Chairman)	1,316	75,750	0.022%
Shelagh Mason	440	25,350	0.007%
John Hearle	430	24,739	0.007%

The Shares were acquired on 31 December 2013 and rank pari passu with the Company's existing ordinary shares.

Copies of the documents relating to the Scrip Dividend Alternative are available for inspection through the National Storage Mechanism (http://www.morningstar.co.uk/uk/NSM).

End

For further information please contact:

MedicX Group                                                                     [phone]

Keith Maddin, Chairman

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

Canaccord Genuity                                                              [phone]

Andrew Zychowski/Helen Goldsmith

Buchanan                                                                          [phone]

Charles Ryland/Sophie McNulty

MedicX Fund Limited                                                           [phone]

David Staples, Chairman

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 123 properties.

The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Conduct Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 31 people operating across the UK.  

The Company's website address is www.medicxfund.com.  Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

 

END

 

 

RDSFMGGMMMVGDZZ